Hemophilia Patient
Gene therapy
Dammam, Saudi Arabia
Mutaz is a 38 year old man, a known case with sever congenital Hemophilia B ( Hemophilia B Factor IX ) which is required factor replacement as needed in case of bleeding. Mutaz was treated with Gene therapy in 20th June, 2022, and he is continues monitoring treatment progress and development.
Disclosure information not submitted.
(PWBD-FR-10.4) Life after gene therapy (Hem B)
Friday, April 25, 2025
3:00 PM - 3:05 PM GST